(Q39563089)

English

Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial

scientific article published on 6 April 2011

In more languages
default values for all languages
No label defined

No description defined

Statements

Pathway analysis of glioblastoma tissue after preoperative treatment with the EGFR tyrosine kinase inhibitor gefitinib--a phase II trial (English)
Annie-Claire Diserens
Mathilde C M Kouwenhoven
Mauro Delorenzi
Marie-France Hamou
Matthias S Matter
Frank L Heppner
Yasuhiro Yonekawa

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit